Drugs / 11C-ZTP-1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07625345 | Jul 2026 → Mar 2029 expected | — | National Institute of Mental Health (NIMH) | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 11C-ZTP-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07625345 ↗ |
| Modality | Diagnostic / imaging agent | “new tracer (\[11C\]ZTP-1) during imaging scans” NCT07625345 ↗ |
| Route | Intravenous | “Injected IV followed by PET scanning” NCT07625345 ↗ |
| Target | PDE4B | “ability to localize and measure PDE4B” NCT07625345 ↗ |